Cargando…
Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients
INTRODUCTION: Lysophosphatidylcholine acyltransferase 1 (LPCAT1) has repeatedly been suggested to be associated with tumorigenesis. To evaluate the role of LPCAT1 in esophageal cancer, LPCAT1 immunostaining was analyzed on a tissue microarray containing samples from esophageal cancer patients. RESUL...
Autores principales: | Bellon, Eugen, Grupp, Katharina, Ghadban, Tarik, Tachezy, Michael, Bachmann, Kai, Izbicki, Jakob Robert, Simon, Ronald, Sauter, Guido, Hube-Magg, Claudia, Melling, Nathaniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397628/ https://www.ncbi.nlm.nih.gov/pubmed/34148155 http://dx.doi.org/10.1007/s00432-021-03686-4 |
Ejemplares similares
-
CD147 expression lacks prognostic relevance in esophageal cancer
por: Küsters, Natalie, et al.
Publicado: (2022) -
RAI3 expression is not associated with clinical outcomes of patients with non-small cell lung cancer
por: Melling, Nathaniel, et al.
Publicado: (2023) -
p53 overexpression is a prognosticator of poor outcome in esophageal cancer
por: Melling, Nathaniel, et al.
Publicado: (2019) -
Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer
por: Lebok, Patrick, et al.
Publicado: (2019) -
Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinoma
por: Jacobsen, Frank, et al.
Publicado: (2020)